http://www.ed.ac.uk/schools-departments/pathway-medicine/home

https://www.cardiff.ac.uk/people/view/1037699-ghazal-peter 

http://www.synthsys.ed.ac.uk/

http://www.eid.ed.ac.uk/

http://www.ed.ac.uk/schools-departments/biomedical-sciences

Peter Ghazal is Professor of Molecular Genetics and Biomedicine.  He is former Head of the Division of Pathway at Edinburgh. He is Sêr Cymru Chair in Systems Medicine, Systems Immunity Research Institute, Cardiff University. 

https://www.cardiff.ac.uk/people/view/1037699-ghazal-peter 

His research interests are aimed towards understanding host-gene network controls of infection, especially those pathways associated with the immune-metabolic axis. Recent studies have been in the field of host genomics of early-life infection, mapping gene networks of systemic host response to infection and understanding the link between sterol metabolism and Interferon-host response. These studies are specifically aimed at the development of new diagnostic and therapeutic strategies, including predictive modelling of host-defence against infection. 

Professor Ghazal is also a founding member of the Genome-Wide RNAi Global Initiative, leading efforts on the development of Minimum Information About an RNAi Experiment, and is an active member of the Systems Biology Graphical Notation group.  He has been a member on number of advisory boards and committees within both academia and industry, and also for charitable and government bodies in the UK, EU, USA and Canada. He is presently Chair of the Virus Scientific Advisory Board for the Wellcome Trust Sanger Institute, and a member of the Scientific Advisory Board for the NIH NIAID Human Immunology Project Consortium.